Advertisements

Propranolol Accord

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Propranolol Accord

What is Propranolol Accord?

Propranolol Accord is a medicinal product containing the active substance propranolol hydrochloride. It belongs to a group of medicines known as beta-adrenoceptor antagonists, more commonly referred to as beta-blockers.

Mechanism of Action

The medication works by blocking the action of certain natural chemicals in the body, such as adrenaline, that affect the heart and blood vessels. By interacting with beta-receptors, the substance helps to decrease the heart rate and reduce the force with which the heart muscle contracts. This action also allows blood vessels to relax, which can facilitate more efficient blood flow throughout the body.

Therapeutic Use

Propranolol Accord is used for the management of various physiological conditions related to the cardiovascular system and the autonomic nervous system. It is primarily prescribed to address issues involving heart rhythm, blood pressure regulation, and the physical symptoms of certain types of anxiety.

In addition to cardiovascular applications, the medication is frequently used in the management of specific neurological and systemic conditions. This includes the prevention of migraine headaches and the reduction of essential tremors. Because of its systemic effects, it may also be used in the management of certain thyroid conditions or to protect the heart following a myocardial infarction.

Advertisements

What side effects are possible with Propranolol Accord?

Possible side effects and safety information

Propranolol Accord has an officially documented safety profile, with potential side effects classified by frequency and affected body system, as established in regulatory documents.

Common adverse reactions (occurring in up to 1 in 10 people) typically involve the Nervous System and Vascular systems, including fatigue, sleep disturbances, cold extremities, and bradycardia (slow heart rate). Gastrointestinal issues such as nausea, vomiting, diarrhea, or constipation are also considered common or sometimes uncommon.

Frequency Category Representative Adverse Reactions
Rare (Up to 1 in 1,000) Thrombocytopenia, hallucinations, psychoses, visual disturbances, bronchospasm, purpura, and alopecia.
Very Rare (Less than 1 in 10,000) Exacerbation of psoriasis.

Serious Adverse Reactions officially noted in labeling include the precipitation of Heart Block or worsening of Heart Failure. Bronchospasm is a key respiratory safety constraint, particularly in individuals with pre-existing obstructive airway disease. Furthermore, the label notes that the medication may mask symptoms of hypoglycemia (low blood sugar), such as fast heart rate, requiring caution, particularly in diabetic patients.

Specific safety statements address certain populations and usage patterns. Severe hepatic or renal impairment requires careful consideration and potential dose adjustment due to altered clearance of the drug. The regulatory profile also warns that abrupt discontinuation of the medicine, especially in patients with ischemic heart disease, carries a risk of exacerbating angina or precipitating a heart attack, necessitating gradual dose reduction.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Propranolol Accord can cause severe, life-threatening effects, and may result in death. Due to the potential for the patient's condition to rapidly deteriorate, immediate emergency medical attention must be sought for any suspected overdose.

Documented Overdose Manifestations

Official regulatory information states that the most serious clinical manifestations of overdose are primarily cardiovascular, but also involve the central nervous system and metabolism. Effects may be delayed and include:

System Affected Key Manifestations
Cardiovascular Profound bradycardia (very slow heartbeat), severe hypotension (low blood pressure), and cardiac failure.
Central Nervous System Neurological symptoms such as confusion, drowsiness, hallucinations, convulsions (seizures), and coma.
Respiratory/Metabolic Bronchospasm and hypoglycemia (low blood sugar), which is a common and significant feature in children.

Required Emergency Actions

If an overdose is suspected, treatment in a medical setting is supportive and symptomatic. Measures may include efforts to reduce drug absorption, such as administration of activated charcoal, and the use of specific emergency medications to counteract severe cardiovascular depression. Immediate medical help is required if symptoms such as fainting, difficulty breathing, a very slow heartbeat, or seizures occur.

Advertisements

Therapeutic Uses of Propranolol Accord

Propranolol Accord: Therapeutic Uses

Propranolol Accord is a prescription beta-blocker medication used to manage several cardiovascular and non-cardiovascular conditions. The primary uses of this drug are centered on regulating heart function and addressing symptoms associated with excessive sympathetic nervous system activity.

Core Indications

The medicine is indicated for the treatment of hypertension (high blood pressure) and angina pectoris (chest pain caused by coronary atherosclerosis). It is also used in the management of certain heart rhythm disorders, known as arrhythmias, and to improve survival after a myocardial infarction (heart attack).

Beyond cardiovascular applications, Propranolol Accord is utilized for:

  • Migraine prophylaxis (prevention of migraine headaches).
  • Treatment of essential tremor.
  • Management of the symptoms of an overactive thyroid gland (thyrotoxicosis).
  • Management of certain high blood pressure conditions, such as those caused by a tumor near the kidneys (pheochromocytoma), and thickened heart muscle (hypertrophic subaortic stenosis).

Quick Facts

Propranolol Accord treats:

  • High blood pressure (hypertension)
  • Chest pain (angina pectoris)
  • Irregular heartbeats (arrhythmias)
  • Prevention of migraine headaches (migraine prophylaxis)
  • Physical symptoms of anxiety
  • Essential tremor

Regulatory References

  1. NIH MedlinePlus guidance
Advertisements

Eligibility and Restrictions for Use

Eligibility for Propranolol Accord is strictly governed by official regulatory labeling, defining populations that are allowed, restricted, or absolutely prohibited from use.

Absolute Contraindications (Must Not Use)

Propranolol Accord is strictly contraindicated in patients with specific severe conditions. These prohibitions include known hypersensitivity to the drug, bronchial asthma or a history of bronchospasm, uncontrolled heart failure, cardiogenic shock, severe bradycardia, second or third-degree heart block (without a pacemaker), and metabolic acidosis. Use is also prohibited for patients with severe peripheral arterial circulatory disturbances and following prolonged fasting.

Restricted Use and Age Rules

Use is conditional and requires caution in patients with significant hepatic or renal impairment, often requiring a lower starting dose due to altered drug clearance. The medicine is generally not recommended during pregnancy unless determined to be essential. For older adults, treatment should commence with the lowest possible dose. The medicine is established for use in adults and for treating arrhythmias in children/adolescents, but its safety and efficacy are not established for many other tablet indications in the general pediatric population.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Propranolol Accord is defined by documented pharmacokinetic changes and reinforced pharmacodynamic effects when co-administered with other substances.

Contraindicated Combinations

Co-administration with the non-dihydropyridine calcium channel blockers Verapamil and Diltiazem is formally contraindicated due to the risk of severe cardiac depression, marked hypotension, and cardiac failure, as stated in regulatory documents. Neither Propranolol nor Verapamil should be given intravenously within 48 hours of discontinuing the other.

Pharmacokinetic Interactions (Exposure Modification)

Interactions often involve cytochrome P450 (CYP) enzymes, which alter the concentration of Propranolol in the body:

  • Increased Exposure: Agents documented to inhibit CYP2D6, CYP1A2, or CYP2C19 metabolism, such as Quinidine, Cimetidine, and certain antidepressants (e.g., Fluoxetine), can increase Propranolol plasma concentrations.
  • Decreased Exposure: Potent enzyme inducers, such as Rifampin, increase the hepatic clearance of Propranolol, which significantly decreases its plasma concentrations and may reduce its therapeutic effect.
  • Reduced Absorption: Cholestyramine and Colestipol are documented to reduce Propranolol plasma concentrations by hindering its absorption.

Pharmacodynamic Interactions and Other Effects

  • Additive Effects: Co-administration with other cardiovascular depressants, including Digoxin, may lead to an additive negative chronotropic effect, increasing the risk of significant bradycardia.
  • Reduced Effect: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as Indometacin are documented to reduce the antihypertensive activity of Propranolol.
  • Substance Interactions: Food intake is officially documented to increase the bioavailability of Propranolol; Cigarette smoking is documented to increase the drug's clearance. Clearance may also be significantly reduced in patients with hepatic or renal impairment, potentially increasing interaction severity.
Advertisements

Mechanism of Action

Propranolol Accord is a non-selective antagonist of adrenergic receptors, primarily blocking beta1 and beta2 receptors in various tissues. This blockade competitively inhibits the binding of endogenous catecholamines, such as adrenaline and noradrenaline.

At the cardiac tissue, beta1 receptor antagonism reduces the signaling cascade that typically increases chronotropy (heart rate) and inotropy (contractility). Consequently, myocardial oxygen demand decreases. Concurrently, Propranolol Accord inhibits sympathetic-driven peripheral vasoconstriction. A separate key mechanism involves the kidneys, where the drug reduces the release of renin from the juxtaglomerular apparatus. Reduced renin activity subsequently lowers the systemic conversion of angiotensinogen, leading to decreased formation of the potent vasoconstrictor, angiotensin II. The combined effects modulate sympathetic tone and the renin-angiotensin-aldosterone system.

Advertisements

Dosage and Administration Information

How to Use Propranolol Accord: Official Administration Guidelines

Propranolol Accord is primarily administered via the oral route for long-term therapy, available as both Immediate-Release (IR) tablets and Extended-Release (XL) capsules. An intravenous (IV) solution is also an approved form for acute management in supervised clinical settings.


Dosing and Frequency Principles

Usage patterns vary based on the specific formulation. Immediate-Release tablets are typically taken in divided doses, two to four times per day, to maintain consistent blood levels. Conversely, the Extended-Release capsules are intended for a once-daily schedule. For treating hypertension, the typical daily dosage range often falls between 160 mg to 320 mg, though a lower initial dose is employed for titration.


Administration Requirements

Procedural Instructions

Administration Constraint Instruction
Extended-Release Forms Must be swallowed whole; do not break, chew, or crush.
Consistency XL/SR capsules should be taken consistently with respect to food (e.g., always with food or always without).

Special Population Guidelines

Treatment for older adults should always begin with the lowest effective dose, requiring careful and conservative titration. Dosage adjustments are also a critical consideration for patients with hepatic impairment, where a lower initial dose is typically advised due to slower drug clearance.


Discontinuation

Therapy should never be stopped abruptly. Standard protocols indicate that the dosage be gradually reduced (tapered) over a period of seven to fourteen days to discontinue the medicine.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Propranolol Accord

The following research overview describes the types of clinical studies that have been conducted for Propranolol Accord, the outcomes they measured, and areas where evidence may be limited, according to regulatory sources and scientific literature. The information here does not constitute medical advice or treatment recommendations.


Evidence for Cardiovascular Indications (Heart and Circulation)

For hypertension (high blood pressure), research examined patterns related to blood pressure change, monitoring changes in both systolic and diastolic measurements. Studies also monitored the incidence of major events such as stroke and other cardiovascular events. Data provide insight into measured patterns in blood pressure measurements in the populations studied. However, comparative evidence is lacking against all newer classes of blood pressure medication in some specific patient groups.

For participants surviving a myocardial infarction (heart attack), large-scale Randomized Controlled Trials (RCTs) monitored long-term clinical endpoints. Findings indicate patterns related to measured changes in the incidence of certain outcomes when therapy was observed in individuals starting treatment shortly after the initial event.

Evidence Structure for Heart Rhythm Disorders (Arrhythmias)

Studies explored outcomes related to systemic or functional imbalance by assessing measures of heart rate control and monitoring the occurrence of irregular rhythm episodes. The evidence base is heterogeneous, meaning the results and study designs vary significantly across the different conditions studied.


Evidence for Neurological and Migraine Indications

For migraine prophylaxis, research has explored the use of the medicine in conditions characterized by fluctuating or episodic manifestations through systematic reviews and placebo-controlled RCTs. Research monitored the frequency of migraine headaches per month. Research highlights changes measured during the study period related to the count of monthly migraine days when compared to placebo groups.

For essential tremor, the medicine was studied for outcomes related to physical discomfort and activity level in placebo-controlled crossover trials. Data provide insight into patterns related to how symptoms evolved in the observed populations, particularly for extremity tremor.


What is Still Uncertain About the Research for Propranolol Accord

Scientific reviews indicate several limitations. Evidence quality varies across studies, and comparative evidence is lacking against all newer therapeutic agents for certain conditions. Furthermore, the evidence highlights what is known and what is still uncertain regarding long-term outcomes and the potential for a sustained response over many years across all studied conditions.

Key Studies & References

  1. Controlled trial of propranolol in hypertension
  2. Beta-blockade after myocardial infarction: systematic review and meta regression analysis
  3. Is propranolol effective for migraine prevention? Is there international consensus for propranolol as prophylactic medication for migraine?
  4. The Therapeutic Potential of Propranolol and Other Beta-Blockers in Hyperthyroidism
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Propranolol Accord (FAQ)

Q: What is the main difference between Propranolol Accord and other types of propranolol?

A: Propranolol Accord is a generic version of the medicine containing the active ingredient propranolol hydrochloride. Official regulatory standards require generic drugs to be bioequivalent to the original brand, meaning they are expected to work in the body in the same way. The main difference is typically found in the inactive ingredients used or the name of the manufacturer.


Q: Do people take Propranolol Accord for high blood pressure, or is it mainly for other conditions?

A: According to the official product information, Propranolol Accord is approved to treat high blood pressure (hypertension). It is also approved for several other conditions, including the prevention of migraines, management of essential tremor, and certain heart rhythm disorders.


Q: How quickly do the effects of Propranolol Accord usually start to be noticed?

A: Studies on the drug's properties indicate that the time it takes for the concentration of the immediate-release tablet to reach its maximum level in the blood (Tmax) is approximately one to four hours after ingestion. This measure provides insight into the speed of initial absorption.


Q: Are there any common supplements or vitamins that interact with Propranolol Accord?

A: Official interaction statements note that the use of multivitamins with minerals may decrease the absorption and effects of propranolol. Regulatory guidance often suggests separating the administration of multivitamins with minerals from this medicine by at least two hours.


Q: What happens if I forget to take a dose of Propranolol Accord?

A: Information in patient resources states that if a dose is missed, it should be taken as soon as it is remembered, unless the time for the next scheduled dose is approaching. Official instructions generally caution against taking two doses at the same time.


Q: Can Propranolol Accord be taken with common pain relievers like ibuprofen?

A: Regulatory information notes that the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a class that includes ibuprofen, may reduce the blood pressure-lowering effect of propranolol. This is a documented interaction where the effect of one drug may change the effect of the other.


Q: Can people with asthma or breathing problems use Propranolol Accord?

A: Propranolol Accord is strictly contraindicated (should not be used) in people who have bronchial asthma or a history of bronchospasm or other obstructive airway diseases. This prohibition is officially noted in prescribing information for patients with these conditions.


Q: What are the major conditions that would prevent someone from being eligible to use Propranolol Accord?

A: Major health conditions that officially prohibit the use of Propranolol Accord include known hypersensitivity to the drug, uncontrolled heart failure, severe bradycardia (very slow heart rate), certain types of heart block (without a pacemaker), and bronchial asthma.


Q: Does alcohol change the effect of Propranolol Accord?

A: Official information indicates that alcohol may increase the amount of propranolol in the body. This increased concentration is noted to potentially be associated with an increased risk of side effects, such as dizziness or lightheadedness.


Q: Does Propranolol Accord affect blood sugar levels?

A: The primary safety information is that the drug may mask the physical warning signs of hypoglycemia (low blood sugar), such as a fast heart rate, making blood sugar monitoring important for diabetic patients.


Q: Can Propranolol Accord interact with herbal remedies, such as St. John's wort?

A: Herbal remedies that are potent inducers of liver enzymes are documented to potentially affect propranolol's metabolism. Specifically, agents like St. John's wort are noted to increase the drug's clearance, which may reduce its overall effectiveness.


Q: Can children or adolescents use Propranolol Accord for certain conditions?

A: Propranolol Accord is established for use in adults and for treating arrhythmias (heart rhythm disorders) in children/adolescents. Specific oral liquid formulations are also approved for conditions like infantile hemangioma in very young children, as authorized for these specific patient populations.


Q: Can I take Propranolol Accord if I have a low heart rate already?

A: The drug is contraindicated (must not be used) in patients with severe bradycardia (very slow heart rate) or certain types of heart block (second or third-degree) without a pacemaker. This is because the drug's mechanism is to slow the heart rate.


Q: Can Propranolol Accord be used by people with diabetes?

A: The official label advises that patients with diabetes use the medicine with caution. This is primarily because the drug may mask the physical symptoms of low blood sugar, such as a rapid heart rate, suggesting that blood glucose monitoring may be necessary.


Q: Is it normal for my hands or feet to feel colder while taking Propranolol Accord?

A: The feeling of cold extremities (hands and feet) is listed as a common adverse reaction in the official prescribing information. This is a common and documented finding in individuals using this medicine.


Q: Can Propranolol Accord cause fatigue or make me feel tired?

A: Fatigue and general tiredness are documented as common adverse reactions in official prescribing information. This is a commonly observed effect noted in the drug's official profile.


Q: Does Propranolol Accord affect sleep or cause strange dreams?

A: Sleep disturbances are listed as documented side effects of the medicine. These effects can specifically include nightmares or vivid dreams, according to official labeling.


Q: How long does Propranolol Accord typically stay in your system?

A: Pharmacokinetic data indicates the half-life of the immediate-release formulation is generally reported to be approximately three to six hours. The half-life is the time it takes for half of the dose to be eliminated from the body.


Q: Does food affect how Propranolol Accord is absorbed or works?

A: Official information states that taking the medicine with food increases the concentration of the drug available to the body (bioavailability). For the extended-release form, regulatory guidance indicates it should be taken consistently with respect to food (always with food or always without).


Q: Do older adults (senior citizens) need to take special precautions with Propranolol Accord?

A: The official guidance emphasizes that treatment for older adults should always begin with the lowest effective dose. This requires careful and conservative dose adjustment due to the way the drug is processed in the body, which can be different in this age group.


Q: What should I do if I experience dizziness after starting Propranolol Accord?

A: Dizziness and lightheadedness are common side effects that can occur when starting this medicine due to changes in blood pressure. Official patient information notes that if these effects are experienced, caution is warranted when driving or performing activities that require coordination.


Q: Is Propranolol Accord intended to be used every day?

A: For most approved indications, Propranolol Accord is intended for long-term therapy and is typically used daily. This includes taking immediate-release forms in divided doses or the extended-release form once daily.


Q: Is Propranolol Accord the same as Inderal?

A: Inderal is a common brand name for the active ingredient, propranolol hydrochloride. Propranolol Accord is a generic version of the medicine. Both contain the same active ingredient and must meet the same government-mandated standards for bioequivalence.


Q: Do studies show Propranolol Accord causes hair loss?

A: Alopecia (hair loss) is officially documented as a rare adverse reaction in the regulatory prescribing information. This means it is an effect observed in a very small number of users during monitoring.


Q: Does Propranolol Accord affect my driving ability?

A: Official patient information notes that the medicine is generally unlikely to affect your ability to drive or operate machinery. However, caution is specifically advised if documented side effects such as dizziness or tiredness are experienced.


Q: How is the safety of Propranolol Accord monitored after it is released to the public?

A: Like all approved medicines, the safety of Propranolol Accord is continuously monitored by regulatory authorities. This is achieved through post-marketing surveillance systems designed to collect data on rare, unexpected, or long-term adverse effects not seen during initial clinical trials.


Q: What is the difference between Propranolol Accord and metoprolol?

A: The difference is related to their pharmacological classification. Propranolol Accord is classified as a non-selective beta-blocker, affecting both beta-1 and beta-2 receptors. In contrast, metoprolol is typically classified as a selective beta-blocker (primarily affecting beta-1 receptors in the heart).


Q: Are eye problems a documented side effect of Propranolol Accord?

A: The official documentation lists visual disturbances as a rare adverse reaction. This indicates that effects related to vision have been documented but occur in a very small fraction of users.


Q: Can Propranolol Accord be used by people with kidney problems?

A: Use requires caution in patients with renal impairment (kidney problems). Official guidelines advise that a lower initial dose is often required due to altered drug clearance, which can affect the body's ability to remove the medicine.


Q: What happens if I stop taking Propranolol Accord suddenly?

A: Abruptly stopping the medicine, particularly in patients with heart disease, is officially warned against. This action carries a documented risk of exacerbating conditions such as angina or precipitating a heart attack. Official prescribing information states that the dosage should be gradually reduced.


Q: Is Propranolol Accord considered a maintenance drug or a short-term treatment?

A: For the majority of its approved chronic conditions, Propranolol Accord is intended for long-term maintenance therapy. This pattern of use aims to manage and stabilize chronic symptoms over an extended period.


Q: How does Propranolol Accord affect the central nervous system?

A: Propranolol Accord is associated with documented Central Nervous System effects. These include common effects such as fatigue, sleep disturbances, and vivid dreams, as well as rare effects such as hallucinations and psychoses.


Q: Is there any evidence that Propranolol Accord is used for migraines?

A: Yes, official prescribing information lists Propranolol Accord as indicated for the prophylaxis (prevention) of common migraine headaches. Studies and official information indicate that it is used to help manage the frequency of these episodes.

Advertisements

How should Propranolol Accord be stored and disposed of?

Storage and Handling Requirements

Official labeling for Propranolol Accord tablets specifies different requirements based on region. US-labeled formulations must be stored at Controlled Room Temperature (20 C to 25 C), protected from both light and moisture, and kept in a tight, light-resistant container. Conversely, some European Summary of Product Characteristics (SmPC) documents state that the medicine does not require any special storage conditions. Regardless of regional variation, all formulations must be kept out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired tablets must be done in accordance with local requirements. It is essential that this medicine not be thrown away via wastewater or household waste to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Propranolol Accord found in:

A-Z Index: